PL375511A1 - Preparat aerozolowy do inhalacji zawierający czynnik antycholinergiczny - Google Patents

Preparat aerozolowy do inhalacji zawierający czynnik antycholinergiczny

Info

Publication number
PL375511A1
PL375511A1 PL03375511A PL37551103A PL375511A1 PL 375511 A1 PL375511 A1 PL 375511A1 PL 03375511 A PL03375511 A PL 03375511A PL 37551103 A PL37551103 A PL 37551103A PL 375511 A1 PL375511 A1 PL 375511A1
Authority
PL
Poland
Prior art keywords
inhalation
aerosol formulation
anticholinergic agent
aza
oxa
Prior art date
Application number
PL03375511A
Other languages
English (en)
Inventor
Friedrich Schmidt
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31979448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL375511(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10237232A external-priority patent/DE10237232A1/de
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL375511A1 publication Critical patent/PL375511A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL03375511A 2002-08-14 2003-07-25 Preparat aerozolowy do inhalacji zawierający czynnik antycholinergiczny PL375511A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237232A DE10237232A1 (de) 2002-08-14 2002-08-14 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE10240257 2002-08-31

Publications (1)

Publication Number Publication Date
PL375511A1 true PL375511A1 (pl) 2005-11-28

Family

ID=31979448

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375511A PL375511A1 (pl) 2002-08-14 2003-07-25 Preparat aerozolowy do inhalacji zawierający czynnik antycholinergiczny

Country Status (31)

Country Link
EP (2) EP1908468A1 (pl)
JP (1) JP4602767B2 (pl)
KR (1) KR101060972B1 (pl)
CN (1) CN1674887A (pl)
AT (1) ATE400265T1 (pl)
AU (1) AU2003298473B9 (pl)
BR (1) BR0313457A (pl)
CA (1) CA2495275C (pl)
CY (1) CY1108776T1 (pl)
DE (1) DE50310117D1 (pl)
DK (1) DK1530464T3 (pl)
EA (1) EA009936B1 (pl)
EC (1) ECSP055600A (pl)
ES (1) ES2305479T3 (pl)
HR (1) HRP20050132A2 (pl)
IL (1) IL166814A (pl)
MX (1) MXPA05001595A (pl)
MY (1) MY142579A (pl)
NO (1) NO20051287D0 (pl)
NZ (1) NZ538743A (pl)
PE (1) PE20040372A1 (pl)
PL (1) PL375511A1 (pl)
PT (1) PT1530464E (pl)
RS (1) RS51396B (pl)
SA (1) SA03240265B1 (pl)
SI (1) SI1530464T1 (pl)
TW (1) TWI317279B (pl)
UA (1) UA81775C2 (pl)
UY (1) UY27938A1 (pl)
WO (1) WO2004022052A1 (pl)
ZA (1) ZA200410325B (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038885A1 (de) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005001297A1 (de) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055960A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055958A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
LT3099172T (lt) 2014-01-31 2021-12-27 AgBiome, Inc. Modifikuotas biologinės kontrolės agentas ir jo naudojimas
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
BR122022010094B1 (pt) 2014-05-07 2023-10-03 Boehringer Ingelheim International Gmbh Dispositivo indicador e recipiente
MX383195B (es) 2014-05-07 2025-03-13 Boehringer Ingelheim Int Recipiente, nebulizador y uso.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10063957A1 (de) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern

Also Published As

Publication number Publication date
JP4602767B2 (ja) 2010-12-22
AU2003298473B2 (en) 2009-04-23
EP1530464B1 (de) 2008-07-09
AU2003298473B9 (en) 2011-06-09
EP1908468A1 (de) 2008-04-09
ECSP055600A (es) 2005-04-18
JP2006506345A (ja) 2006-02-23
AU2003298473A1 (en) 2004-03-29
TW200406213A (en) 2004-05-01
RS20050074A (sr) 2007-09-21
CY1108776T1 (el) 2014-04-09
NZ538743A (en) 2006-05-26
ES2305479T3 (es) 2008-11-01
NO20051287L (no) 2005-03-11
UY27938A1 (es) 2004-03-31
EP1530464A1 (de) 2005-05-18
IL166814A0 (en) 2006-01-15
NO20051287D0 (no) 2005-03-11
MXPA05001595A (es) 2005-04-25
WO2004022052A1 (de) 2004-03-18
BR0313457A (pt) 2005-06-21
CA2495275C (en) 2012-04-17
EA009936B1 (ru) 2008-04-28
TWI317279B (en) 2009-11-21
ZA200410325B (en) 2006-10-25
RS51396B (sr) 2011-02-28
EA200500292A1 (ru) 2005-10-27
UA81775C2 (uk) 2008-02-11
HRP20050132A2 (en) 2006-05-31
DE50310117D1 (de) 2008-08-21
KR20050049478A (ko) 2005-05-25
PE20040372A1 (es) 2004-08-03
CA2495275A1 (en) 2004-03-18
SA03240265B1 (ar) 2009-11-10
SI1530464T1 (sl) 2008-12-31
IL166814A (en) 2010-11-30
CN1674887A (zh) 2005-09-28
MY142579A (en) 2010-12-15
ATE400265T1 (de) 2008-07-15
KR101060972B1 (ko) 2011-09-01
PT1530464E (pt) 2008-08-28
DK1530464T3 (da) 2008-09-08

Similar Documents

Publication Publication Date Title
CY1108776T1 (el) Σκευασμα αερολυματος για εισπνοη που περιεχει αντιχολινεργικο
WO2005030211A8 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
EP1785136A3 (de) Inhalative Arzneimittel enthaltend ein Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
JP2006506345A5 (pl)
AR039404A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion
WO2007060108A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
WO2007060104A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
WO2002000166A3 (en) New compounds useful as antibacterial agents
ZA200409676B (en) Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase
WO2002036104A3 (de) Inhalative lösungsformulierung mit einem tiotropiumsalz
TH65183A (th) สูตรผสมแอโรซอลสำหรับยาสูดซึ่งประกอบรวมด้วยแอนติโคลิเนอร์จิก
TH78671A (th) สูตรผสมแอโรซอลสำหรับการสูดดม ซึ่งประกอบรวมด้วยแอนติโคลิเนอร์จิก
AR040864A1 (es) Formulacion aerosol para inhalacion, que contiene un agente anticolinergico
TH75872A (th) สูตรผสมชนิดแอโรซอลสำหรับการสูดดมเบต้า-อะโกนิสต์

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)